A new AI method has been developed to improve care for patients with type 2 diabetes mellitus who need complex treatment.
One in 10 adults worldwide have been diagnosed with type 2 diabetes, but a smaller number require multiple medications to control blood glucose levels and avoid serious complications, such as loss of vision and kidney disease.
For this smaller group of patients, physicians may have limited clinical decision-making experience or evidence-based guidance for choosing drug combinations.
A solution could be to expand the number of patients to support development of general principles to guide decision-making.
Combining patient data from multiple healthcare institutions, however, requires deep expertise in AI and wide-ranging experience in developing machine learning models using sensitive and complex healthcare data.
Researchers have developed a new AI method that analysed electronic health record data and learned generalisable treatment patterns of type 2 diabetes patients with similar characteristics.
Those patterns can now be used to help determine an optimal drug regimen for a specific patient.
The new AI method initially groups patients with similar disease states and then analyses their treatment patterns and clinical outcomes.
It then matches the patient of interest to the disease state groups and predicts the range of potential outcomes for the patient depending on various treatment options.
Researchers evaluated how well the method worked in predicting successful outcomes given drug regimens administered to patient with diabetes in Utah and Indiana.
The algorithm was able to support medication selection for more than 83 per cent of patients, even when two or more medications were used together.
In the future, the research team expects to help patients with diabetes who require complex treatment in checking the efficacy of various drug combinations and then, with their doctors, deciding on a treatment plan that is right for them.
The study involved researchers at Hitachi and the University of Utah Health.
Hitachi aims to accelerate this area of innovation, including via the practical application of the technology through collaboration between its healthcare and IT business divisions and R&D group.
UK Biobank releases world’s largest single set of sequencing data
Listen: Longevity, Eastern wisdom and Western science
Fundamental principles of healthcare digital twins
Tackling the diagnostic testing sustainability problem
Gym-going men ‘unaware’ of protein risk to fertility
Anti-choke mug protects Parkinson’s patients
AI model predicts breast cancer risk without racial bias
TheHill secures UK gov funding and Barclays support to help advance digital innovation
Real time data collection changes the game for the stroke patient pathway
Inside BT’s mission to boost NHS connectivity
- Products4 weeks ago
Pioneering paediatric pressure ulcer mattress to be showcased at MEDICA 2023
- Diagnostics3 weeks ago
3D model will advance understanding of spinal injury pathology
- Opinion4 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- Biotech4 weeks ago
LiliumX unveils rebrand as Valink Therapeutics and appointment of new board and execs after securing $7.8m investment